temozolomide has been researched along with cyclin d1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agnihotri, S; Aldape, K; Clarke, ID; Dirks, PB; Fuller, GN; Gajadhar, A; Guha, A; Hawkins, C; Kesari, S; McGlade, CJ; Mischel, PS; Munoz, DM; Restrepo, A; Smith, CJ; Stanford, WL; Wolf, A | 1 |
| Chen, J; Hu, G; Lu, Y; Luo, C; Qian, J; Wang, J; Wang, Q | 1 |
| Belmonte, G; Miracco, C; Pirtoli, L; Tini, P; Toscano, M | 1 |
| Dai, D; Li, Y; Li, Z; Lu, Y; Wang, C; Wang, J; Zhang, D; Zhou, M | 1 |
| Chen, Y; Jiang, W; Kuang, W; Liu, Z; Tian, Y | 1 |
| Alaniz, L; Berner, S; Bonadeo, N; Cervio, A; Chimento, A; Cristina, C; Demarchi, G; Perrone, S; Sevlever, G; Spinelli, FM; Valla, S; Vitale, DL | 1 |
6 other study(ies) available for temozolomide and cyclin d1
| Article | Year |
|---|---|
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; GATA4 Transcription Factor; Glioblastoma; Humans; Mice; Promoter Regions, Genetic; Temozolomide; Tumor Suppressor Proteins | 2011 |
Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cells.
Topics: Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin D1; Dacarbazine; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glioma; Green Fluorescent Proteins; GTPase-Activating Proteins; Humans; Multidrug Resistance-Associated Proteins; Neoplasm Invasiveness; RNA Interference; RNA, Messenger; RNA, Small Interfering; Temozolomide; Time Factors; Transfection | 2013 |
Cyclin D1 Co-localizes with Beclin-1 in Glioblastoma Recurrences: A Clue to a Therapy-induced, Autophagy-mediated Degradative Mechanism?
Topics: Adult; Apoptosis; Autophagy; Beclin-1; Cell Line, Tumor; Cyclin D1; Dacarbazine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Temozolomide | 2016 |
Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
Topics: Adult; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Middle Aged; Temozolomide | 2018 |
The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ).
Topics: Brain Neoplasms; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Glioma; Humans; MicroRNAs; Polycomb Repressive Complex 2; Temozolomide | 2021 |
β-Catenin is reduced in membranes of human prolactinoma cells and it is inhibited by temozolomide in prolactin secreting tumor models.
Topics: Animals; beta Catenin; Cyclin D1; Humans; Mice; Models, Theoretical; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide | 2022 |